5
Oswali Chemicals Ltd
506916 BSE
Oswali Chemicals Ltd
BSE: 506916
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Oswali Chemicals Ltd insights
25 extracted metrics + investor summaries across FY06–FY25.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company is almost debt free.
- Company has delivered good profit growth of 81.1% CAGR over last 5 years
Weaknesses
1- Earnings include an other income of Rs.6.49 Cr.
Growth Rate
Revenue Growth
-
Net Income Growth
32450.00% →
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.89 | 0.73 | 1.97 | 0.99 | 1.43 | 2 | 2.7 | 3.77 | 6.25 | 6.18 | 11.1 | 13.37 |
| Expenses | 3.43 | 2.78 | 4.2 | 3.98 | 5.43 | 5.06 | 6.6 | 7.27 | 8.95 | 9.59 | 9.8 | 10.66 |
| Financing Profit | -2.58 | -2.1 | -2.34 | -3.35 | -4.57 | -3.93 | -5.31 | -5.13 | -4.52 | -5.95 | -1.64 | -0.29 |
| Fin. Margin % | -289.89% | -287.67% | -118.78% | -338.38% | -319.58% | -196.5% | -196.67% | -136.07% | -72.32% | -96.28% | -14.77% | -2.17% |
| Other Income | 0 | 0 | 0 | 0 | 0.02 | 0.13 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Interest | 0.04 | 0.05 | 0.11 | 0.36 | 0.57 | 0.87 | 1.41 | 1.63 | 1.82 | 2.54 | 2.94 | 3 |
| Depreciation | 0.22 | 0.25 | 0.28 | 0.32 | 0.33 | 0.35 | 0.43 | 0.49 | 0.5 | 0.52 | 0.56 | 0.6 |
| PBT | -2.8 | -2.35 | -2.62 | -3.67 | -4.88 | -4.15 | -5.74 | -5.62 | -5.02 | -6.47 | -2.2 | -0.88 |
| Tax % | 1.07% | 0% | -3.82% | -3.27% | -111.68% | 1.93% | -2.96% | -67.44% | -21.91% | -25.19% | -25.91% | -101.14% |
| Net Profit | -2.83 | -2.35 | -2.51 | -3.55 | 0.56 | -4.23 | -5.57 | -1.83 | -3.92 | -4.84 | -1.63 | 0.01 |
| EPS in Rs | — | — | — | — | 0.1 | -0.78 | -1.02 | -0.34 | -0.72 | -0.89 | -0.3 | 0 |
Profit & Loss
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | |
|---|---|---|---|---|---|---|
| Sales | -0.01 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.36 | 0 | 0.02 | 0.75 | 0.02 | 0.02 |
| Operating Profit | -0.37 | 0 | -0.02 | -0.75 | -0.02 | -0.02 |
| Other Income | -0.02 | 0 | 0 | 1.44 | 0 | 6.49 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | -0.39 | 0 | -0.02 | 0.69 | -0.02 | 6.47 |
| Tax % | 0% | — | 0% | 10.14% | 0% | 0% |
| Net Profit | -0.39 | 0 | -0.02 | 0.62 | -0.02 | 6.47 |
| Div. Payout % | 0% | — | 0% | 0% | 0% | 0% |
Balance Sheet
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 |
| Reserves | -7.68 | -7.68 | -7.7 | -7.08 | -7.1 | -0.62 |
| Borrowings | 0 | 0.49 | 0 | 0 | 0 | 0 |
| Other Liabilities | 6.98 | 6.49 | 7 | 6.69 | 6.69 | 0.13 |
| Total Liabilities | 0.15 | 0.15 | 0.15 | 0.46 | 0.44 | 0.36 |
| Fixed Assets | 0.15 | 0.15 | 0.15 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0.46 | 0.44 | 0.36 |
| Total Assets | 0.15 | 0.15 | 0.15 | 0.46 | 0.44 | 0.36 |
Cash Flow
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Operating | 0 | -60 | -78 |
| Investing | -4 | -1 | -1 |
| Financing | 9 | 60 | 92 |
| Net Cash Flow | 5 | -1 | 13 |
Ratios
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | |
|---|---|---|---|---|---|---|
| Debtor Days | 0 | — | — | — | — | — |
| Inventory Days | 0 | — | — | — | — | — |
| Cash Conversion Cycle | 0 | — | — | — | — | — |
| Working Capital Days | -2,54,770 | — | — | — | — | — |
Documents
1
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
11h - Postal ballot e-voting results: resolutions passed; scrutinizer report March 9, 2026; deemed passed March 8, 2026. 11h - Postal ballot e-voting results: resolutions passed; scrutinizer report March 9, 2026; deemed passed March 8, 2026.
2
Announcement under Regulation 30 (LODR)-Newspaper Publication
2m - Find Attached Intimation of Newspaper Publication pertaining to Corrigendum of Postal Ballot Notice. 2m - Find Attached Intimation of Newspaper Publication pertaining to Corrigendum of Postal Ballot Notice.
4
Board Meeting Outcome for Outcome Of Finance Committee Meeting For Allotment Of 45,00,000 Equity Shares Pursuant To Exercise Of Convertible Equity Warrants Allotted On Preferential Basis.
25 Feb - Allotted 4,500,000 shares on Feb 25, 2026 at Rs39; paid-up capital now 5,89,24,212 25 Feb - Allotted 4,500,000 shares on Feb 25, 2026 at Rs39; paid-up capital now 5,89,24,212
5
Draft Letter of Offer
24 Feb - Acquirers to buy 26% (1,76,48,152 shares) at ₹55 each (₹97.06 crore); offer Apr 8–22, 2026. 24 Feb - Acquirers to buy 26% (1,76,48,152 shares) at ₹55 each (₹97.06 crore); offer Apr 8–22, 2026.
Frequently Asked Questions about Oswali Chemicals Ltd
Where is Oswali Chemicals Ltd (506916) listed?
Oswali Chemicals Ltd is listed on the Indian stock exchanges. It is listed on BSE: 506916. You can view its live share price, financials, and ratios on Tapetide.
How can I research Oswali Chemicals Ltd on Tapetide?
On Tapetide, you can view Oswali Chemicals Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Face Value ₹ 10